Volume 11,Issue 3
Observation on the Efficacy of Budesonide Formoterol Powder Inhalation as an Adjuvant Treatment for COPD Associated with Pulmonary Heart Disease
Objective: In this study, we deeply explore the value of budesonide and formoterol powder inhalation as adjuvant therapy for patients with COPD and cor pulmonale. Methods: The time node was selected from 2021.5 to 2023.2, and a total of 50 patients were included, all with COPD and pulmonary heart disease. Two groups were divided into two groups by random grouping, taking budesonide formoterol powder inhalation and conventional treatment, respectively, and then the efficacy was compared. Results: The treatment effect of the observation group was higher than that of the control group, and the result comparison was P < 0.05. The pulmonary function indicators were all higher than those of the control group, P < 0.05; the PaCO2 index of the observation group decreased and was lower than that of the control group; the PaO2 index increased, and was higher than that of the control group, P < 0.05; the incidence of adverse reactions in the observation group was lower than that of the control group, P < 0.05. Conclusion: When treating COPD patients with cor pulmonale, taking budesonide formoterol powder inhalation can improve the therapeutic effect, improve lung function indicators and PaCO2 and PaO2 indices, reduce adverse reactions, and ensure the safety of patients during treatment.
[1] Xiong W, Zhao D, 2022, Improvement of Lung Function in Patients with Chronic Obstructive Pulmonary Disease and Bronchial Asthma. Journal of Rational Clinical Drug Use, 15(15): 70–72.
[2] Huang Z, Zhao S, Wang X, 2022, Clinical Efficacy of Budesonide Formoterol Powder Inhalation in the Treatment of Elderly Patients with COPD and Its Effect on the Expression of Inflammatory Factors and Amyloid A. Journal of Xinjiang Medical University, 45(1): 59–63.
[3] Liu T, 2021, Effect of Budesonide Formoterol Powder Inhalation on Lung Function in Elderly Patients with COPD. Chinese Practical Medicine, 16(8): 21–23.
[4] Li H, 2021, Effect of Budesonide and Formoterol Inhalation Therapy on Patients with Stable COPD and Lung Cancer. Journal of Mathematical Medicine, 34(3): 428–429.
[5] Wang Y, Li L, 2021, Effect of Budesonide and Formoterol on Respiratory Function in Patients with Chronic Obstructive Pulmonary Disease. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 31(4): 32–33.
[6] Huang Z, Deng C, Xie S, 2022, Analysis of the Efficacy of Budesonide Formoterol Inhalation in Patients with Chronic Obstructive Pulmonary Disease and Asthma. Pharmaceutical Biotechnology, 29(4): 362–366.
[7] Fan S, 2021, Observation on the Efficacy of Bufei Pingchuan Recipe Combined with Budesonide and Formoterol Powder Inhalation in the Treatment of Lung and Kidney Yang Deficiency Syndrome in the Acute Exacerbation of COPD. Journal of Modern Integrated Traditional Chinese and Western Medicine, 30(24): 2693–2696.
[8] Bian M, Bu L, 2022, Comparative Study on the Effects of Budegrefur Inhalation Aerosol and Budesonide Formoterol Powder Inhalation on Lung Function and Quality of Life in Patients with COPD in Remission. Practical Drugs and Clinics, 25(1): 42–45.
[9] Li C, Gao J, Wang H, 2023, The Efficacy of Budesonide Formoterol Powder Inhalation Combined with Montelukast in the Treatment of Elderly Patients with COPD Asthma Overlap Syndrome. Chinese Journal of Coal Industry Medicine, 26(1): 108–112.
[10] Cui K, Lin Z, Gu X, 2022, Observation on the Application Effect of Budesonide Formoterol Powder Inhalation Combined with Tiotropium Bromide Powder Inhalation in Elderly Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Chinese Medicine, 17(9): 1343–1347.